CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Arhaus (ARHS) Gears Up to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Arhaus' (ARHS) third-quarter 2023 results are likely to have gained from robust demand for products, strength in the showroom and e-commerce channels and normalization of the supply chain.
Wall Street Analysts Look Bullish on CVS Health (CVS): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Overstock (OSTK) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Overstock's (OSTK) third-quarter 2023 results are likely to reflect strength in the Bed Bath & Beyond brand. However, weakening consumer engagement in the housing market is likely to have been a concern.
What's in Store for STMicroelectronics (STM) in Q3 Earnings?
by Zacks Equity Research
STMicroelectronics' (STM) third-quarter results are likely to reflect product portfolio strength and end-market momentum despite macroeconomic challenges.
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
What to Note Ahead of Deckers Outdoor's (DECK) Q2 Earnings
by Zacks Equity Research
Deckers Outdoor's (DECK) Q2 results might have been hurt by softness across its brands, rising expenses and macroeconomic headwinds. Its customer-centric product and marketing strategies are likely to have been tailwinds.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $68.97, marking a -0.03% move from the previous day.
CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health (CVS) Q3 revenues will likely benefit from growth in specialty pharmacy and brand inflation and increased prescription and front store volume.
Is Invesco S&P 100 Equal Weight ETF (EQWL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EQWL
CVS Health (CVS) Stock Moves -1.28%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $71.09 in the latest trading session, marking a -1.28% move from the prior day.
Bear of the Day: Walgreens Boots Alliance (WBA)
by Brian Bolan
Competition heated up and Walgreens got the boot.
Is There Enough Value to Buy CVS or Best Buy Stock for a Rebound?
by Shaun Pruitt
When it comes to value investing, Best Buy (BBY) and CVS (CVS) stock should certainly be on investors' radars but is it time to buy?
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
CVS Health (CVS) Stock Moves -0.63%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $69.25, marking a -0.63% move from the previous day.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors continue to remain optimistic about CVS Health (CVS) due to the new acquisitions and the strong execution of the pharmacy business.
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $71.33 in the latest trading session, marking a -1.71% move from the prior day.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Zacks Analyst Blog Highlights Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health
by Zacks Equity Research
Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health are part of the Zacks top Analyst Blog.
Top Research Reports for Eli Lilly, Toyota Motor, Accenture & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Toyota Motor Corporation (TM) and Accenture plc (ACN).